Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **collagen triple helix** is a structural motif formed by the association of three polypeptide chains with a Gly–Xaa–Yaa repeating triplet pattern, where proline and 4-hydroxyproline are common in Xaa and Yaa positions, respectively[1][2][4]. The triple helix is stabilized by interchain hydrogen bonds, water-mediated networks, and specific stereoelectronic effects, particularly from 4-hydroxyproline residues[2][4]. Formation and stabilization of this structure are critical for functional collagen fibers, which provide structural support and integrity to the extracellular matrix of connective tissues[1][2][3]. Disruptions—due to genetic mutations or altered post-translational modifications—can result in various connective tissue diseases, including osteogenesis imperfecta and Ehlers-Danlos syndromes[4]. The triple helix itself is not a single molecule, receptor, or enzyme, but rather a motif or conformation shared by all collagen proteins; therefore, it is not directly druggable as a therapeutic target, though stabilization strategies are studied in peptide engineering and regenerative medicine for modulating collagen stability[2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Collagen triple helix.